港股異動 | 都市麗人(2298.HK)收漲10.17% 月內已累漲50% 獲多位高管增持
格隆匯9月10日丨都市麗人(2298.HK)今日收報0.65港元,漲10.17%,成交1593萬港元,最新總市值14.6億港元,該股自9月以來持續上漲,迄今已累漲50%。都市麗人的多位高管近日頻繁增持股份彰顯信心,其中,公司執行董事張盛峯於8月31日、9月1日、9月2日及9月3日通過其全資擁有的子公司信鋒國際有限公司累計增持公司468.7萬股,約合已發行總股本的0.21%。9月7日張盛鋒再次增持83.4萬股,增持後,其最新持股比例升至9.86%。此外,都市麗人創始人兼董事長鄭耀南於9月4日及7日合計增持235.1萬股,增持後,其最新持股比例升至34.97%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.